Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Yerly

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Echocardiography (Mount Kisco, N.Y.)|February 1, 2011
Reduced atrial emptying after orthotopic heart transplantation masquerading as restrictive transmitral Doppler flow pattern?*Patrizio Pascale, Pierre Monney, Xavier Jeanrenaud, et al.
The European Respiratory Journal|January 20, 2018
First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertensionCécile Daccord, Igor Letovanec, Patrick Yerly, et al.
Revue Medicale Suisse|May 26, 2018
[Therapeutic options in advanced heart failure : place of durable left ventricular assist device (LVAD)]Julien Regamey, Matthias Kirsch, Piergiorgio Tozzi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 3, 2026
Low-dose levosimendan infusions in advanced heart failure: efficacy, safety, and factors associated with outcomesNicolas Barras, John Kikoïne, Lucas Liaudet, et al.
Xenotransplantation|January 10, 2022
Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantationPatrick Yerly, Samuel Rotman, Julien Regamey, et al.
ESC Heart Failure|December 2, 2021
Body composition and maximal exercise capacity after heart transplantationJulien Regamey, Pierre Monney, Patrick Yerly, et al.
Transplantation|July 2, 2014
Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantationPatrick Yerly, Samuel Rotman, Antoine Nobile, et al.
Swiss Medical Weekly|June 7, 2021
Two-dimensional transthoracic echocardiography at rest for the diagnosis, screening and management of pulmonary hypertensionNicolas Brugger, Mona Lichtblau, Micha Maeder, et al.
Transplantation|February 28, 2018
Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver TransplantationJulien Vionnet, Patrick Yerly, John-David Aubert, et al.
Frontiers in Cardiovascular Medicine|November 17, 2022
Case report: Disseminated <i>Scedosporium apiospermum</i> infection with invasive right atrial mass in a heart transplant patientBaudouin Bourlond, Ana Cipriano, Julien Regamey, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Echocardiography (Mount Kisco, N.Y.)|February 1, 2011
Reduced atrial emptying after orthotopic heart transplantation masquerading as restrictive transmitral Doppler flow pattern?*Patrizio Pascale, Pierre Monney, Xavier Jeanrenaud, et al.
The European Respiratory Journal|January 20, 2018
First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertensionCécile Daccord, Igor Letovanec, Patrick Yerly, et al.
Revue Medicale Suisse|May 26, 2018
[Therapeutic options in advanced heart failure : place of durable left ventricular assist device (LVAD)]Julien Regamey, Matthias Kirsch, Piergiorgio Tozzi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 3, 2026
Low-dose levosimendan infusions in advanced heart failure: efficacy, safety, and factors associated with outcomesNicolas Barras, John Kikoïne, Lucas Liaudet, et al.
Xenotransplantation|January 10, 2022
Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantationPatrick Yerly, Samuel Rotman, Julien Regamey, et al.
ESC Heart Failure|December 2, 2021
Body composition and maximal exercise capacity after heart transplantationJulien Regamey, Pierre Monney, Patrick Yerly, et al.
Transplantation|July 2, 2014
Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantationPatrick Yerly, Samuel Rotman, Antoine Nobile, et al.
Swiss Medical Weekly|June 7, 2021
Two-dimensional transthoracic echocardiography at rest for the diagnosis, screening and management of pulmonary hypertensionNicolas Brugger, Mona Lichtblau, Micha Maeder, et al.
Transplantation|February 28, 2018
Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver TransplantationJulien Vionnet, Patrick Yerly, John-David Aubert, et al.
Frontiers in Cardiovascular Medicine|November 17, 2022
Case report: Disseminated <i>Scedosporium apiospermum</i> infection with invasive right atrial mass in a heart transplant patientBaudouin Bourlond, Ana Cipriano, Julien Regamey, et al.
Pageof 7